First Header Logo Second Header Logo

Search Result Details

This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to Rocha Lima, Caio Max
Item TypeName
Concept Drug Administration Schedule
Academic Article Bortezomib with or without irinotecan in relapsed or refractory colorectal cancer: results from a randomized phase II study.
Academic Article A phase II trial of perifosine in locally advanced, unresectable, or metastatic pancreatic adenocarcinoma.
Academic Article A phase I study of sequential administration of escalating doses of intravenous paclitaxel, oral topotecan, and fixed-dose oral etoposide in patients with solid tumors.
Academic Article Oxaliplatin and fixed-rate infusional gemcitabine in the second-line treatment of patients with metastatic colon cancer: final results of a Phase II trial prematurely closed as a result of poor accrual.
Academic Article Timing of adjuvant and neoadjuvant therapy in colorectal cancers.
Academic Article A phase 1 trial of E7974 administered on day 1 of a 21-day cycle in patients with advanced solid tumors.
Academic Article A phase II trial of nab-Paclitaxel as second-line therapy in patients with advanced pancreatic cancer.
Academic Article A Phase I Clinical, Pharmacokinetic, and Pharmacodynamic Study of Weekly or Every Three Week Ixabepilone and Daily Sunitinib in Patients with Advanced Solid Tumors.
Academic Article Addition of algenpantucel-L immunotherapy to standard adjuvant therapy for pancreatic cancer: a phase 2 study.
Academic Article Advances in treatment of inoperable NSCLC: gemcitabine doublets--a promising alternative.
Academic Article A multicenter phase II study of G17DT immunogen plus irinotecan in pretreated metastatic colorectal cancer progressing on irinotecan.
Search Criteria
  • Appointments and Schedules